等待开盘 04-03 09:30:00 美东时间
+0.090
+0.31%
Piper Sandler analyst Matthew Clark maintains Avidbank Holdings (NASDAQ:AVBH) with a Overweight and lowers the price target from $37 to $35.
04-02 20:54
Avidbank Holdings appoints Keith Jensen to board of directors Avidbank Holdings said Keith Jensen joined its board of directors. Jensen is a corporate finance veteran and has served as CFO at public and private technology companies. His most recent role was Chief Financial Officer at Fortinet. Discl
03-13 20:24
今日重点评级关注:Ascendiant Capital:维持IGC Pharma"买入"评级,目标价从4.75美元升至5美元;Brookline Capital:维持C4 Therapeutics"买入"评级,目标价从20美元升至30美元
02-24 10:27
Stephens & Co. analyst Andrew Terrell maintains Avidbank Holdings (NASDAQ:AVBH) with a Overweight and raises the price target from $30 to $35.
02-24 01:20
Avidbank Director Mike Rosinus Reports Sale of Common Shares Mike Rosinus, a director of Avidbank Holdings Inc., reported the disposal of common shares of the company. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Technologies (PUBT) using
02-13 09:26
Avidbank swings to Q4 net income Overview California bank's Q4 net income recovered from previous quarter's loss Net interest margin expanded to 4.13% in Q4 2025 Company's Q4 non-performing assets increased due to loan downgrades Outlook Company expresses confidence in asset quality and loan portfol
01-30 05:26
Avidbank Holdings Inc. Files Initial Beneficial Ownership Statement for Elisabeth Foussianes, EVP and Chief Credit Officer Avidbank Holdings Inc. has filed an initial statement of beneficial ownership with the U.S. Securities and Exchange Commission. The filing lists Elisabeth Foussianes, who serves
01-22 06:04
Avidbank Holdings (NASDAQ:AVBH) reported quarterly losses of $(0.72) per share which missed the analyst consensus estimate of $(0.47) by 53.52 percent.
2025-10-24 04:09
Avidbank Holdings Inc. will release its third quarter 2025 earnings results after market close on Thursday, October 23, 2025, with results available at www.avidbank.com under About Us, Investor Relati...
2025-10-09 03:10
今日重点评级关注:HC Wainwright & Co.:维持曼恩凯德生物医疗"买入"评级,目标价从9美元升至11美元;杰富瑞:维持Ionis Pharmaceuticals"买入"评级,目标价从83美元升至96美元
2025-09-03 10:20